Ullman Publishes Article Regarding FDA Warning Letters to Amazon

March 29, 2024 | Marc S. Ullman | Compliance, Investigations & White Collar

Marc S. Ullman, of counsel to Rivkin Radler, recently authored “FDA sends a message with two warning letters to Amazon” in Natural Products Insider.

In the article, Marc explains the importance of the FDA warning letters on homeopathic “supplements” and products that contain active pharmaceutical ingredients. Ullman writes, “During the last quarter of 2023, the U.S. Food and Drug Administration issued two warning letters to Amazon.com Inc. (Amazon) that when viewed in isolation and on their surface seemed quite curious, as well as potentially creating significant burdens for all retailers.” 

“A closer reading of the letters and some research into the multiple products cited in each suggests FDA’s reasons for issuing the warnings are consistent, straightforward and applicable to all retailers. Why FDA was not equally straightforward in describing the rationale in a manner that provides clear notice to retailers of all regulated products is a question for another day.”

To read the full article, please click here.

Share this article:

Related Publications

Get legal updates and news delivered to your inbox